Last 47 quarters of trend data · Consumer Cyclical · Specialty Retail
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Bath & Body Works, Inc.'s quarterly P/E stands at 17.0x, up 12.9% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has expanded 10.6% YoY to 11.1x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 6.30 | 17.00 | 23.48 | 15.91 | 4.50 | 15.06 | 12.21 | 29.47 | 4.18 | 13.60 | 21.24 | 25.07 | 6.09 |
| — | +12.9% | +92.3% | -46.0% | +7.6% | +10.7% | -42.5% | +17.5% | -31.3% | -35.2% | +24.3% | +21.4% | -1.0% | |
| P/S Ratio | 0.67 | 0.81 | 0.96 | 1.18 | 0.73 | 0.98 | 1.21 | 1.88 | 0.83 | 1.03 | 1.34 | 1.45 | 0.92 |
| — | -17.4% | -20.7% | -37.3% | -11.9% | -4.7% | -9.6% | +29.8% | -9.2% | -13.9% | +5.8% | -34.8% | -24.2% | |
| P/B Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 7.45 | — | — | 11.10 | 2.28 | — | — | 86.58 | 2.76 | — | — | — | 2.64 |
| — | — | — | -87.2% | -17.3% | — | — | — | +4.3% | — | — | — | -26.6% | |
| EV / EBITDA | 5.94 | 11.08 | 11.98 | 10.12 | 4.15 | 10.01 | 12.06 | 14.53 | 4.63 | 10.09 | 13.26 | 13.32 | 5.42 |
| — | +10.6% | -0.7% | -30.3% | -10.3% | -0.8% | -9.0% | +9.0% | -14.5% | -22.7% | +13.2% | -2.7% | +8.2% | |
| EV / EBIT | 7.27 | 14.51 | 16.24 | 12.73 | 4.53 | 12.95 | 13.32 | 18.74 | 5.00 | 12.09 | 15.81 | 16.18 | 5.82 |
| — | +12.1% | +22.0% | -32.1% | -9.4% | +7.1% | -15.7% | +15.9% | -14.1% | -26.5% | +11.6% | -0.3% | +9.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Bath & Body Works, Inc.'s operating margin was 10.1% in Q3 2025, down 0.0 pp QoQ and down 3.4 pp YoY. The trailing four-quarter average of 14.8% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 5.1% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.3% | 41.3% | 41.3% | 45.4% | 46.7% | 43.5% | 41.0% | 43.8% | 45.9% | 43.7% | 39.9% | 42.7% | 43.2% |
| — | -5.1% | +0.7% | +3.6% | +1.7% | -0.4% | +2.8% | +2.6% | +6.1% | +3.3% | -2.2% | -7.5% | -9.4% | |
| Operating Margin | 17.3% | 10.1% | 10.1% | 14.7% | 24.3% | 13.5% | 12.0% | 13.5% | 23.9% | 14.1% | 12.1% | 13.0% | 22.6% |
| — | -25.4% | -15.5% | +8.6% | +1.9% | -4.3% | -0.6% | +4.2% | +5.7% | +12.3% | -19.4% | -32.9% | -22.2% | |
| Net Margin | 10.9% | 4.8% | 4.1% | 7.4% | 16.3% | 6.6% | 10.0% | 6.3% | 19.9% | 7.6% | 6.4% | 5.8% | 15.0% |
| — | -26.6% | -58.5% | +17.3% | -18.3% | -13.6% | +56.9% | +8.3% | +32.3% | +34.3% | -14.4% | -45.7% | -23.4% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROA | 15.4% | 1.6% | 1.3% | 2.2% | 9.2% | 2.1% | 3.0% | 1.6% | 10.8% | 2.3% | 1.9% | 1.5% | 8.2% |
| — | -26.4% | -55.8% | +32.2% | -15.0% | -6.4% | +59.4% | +9.1% | +32.4% | +25.7% | -23.7% | -47.6% | -17.1% | |
| ROIC | 32.9% | 3.9% | 3.9% | 5.4% | 16.1% | 5.0% | 4.5% | 4.8% | 17.3% | 5.4% | 4.9% | 5.0% | 16.9% |
| — | -22.5% | -13.1% | +11.6% | -6.8% | -7.8% | -8.3% | -4.0% | +2.2% | +9.4% | -22.7% | -36.9% | -30.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Bath & Body Works, Inc.'s Debt/EBITDA ratio is 22.2x — elevated, raising questions about debt serviceability. The current ratio has improved 10.9% YoY to 1.21x, strengthening the short-term liquidity position.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | 3.20 | 22.23 | 22.60 | 18.25 | 6.62 | 18.66 | 21.12 | 21.16 | 7.28 | 19.62 | 23.19 | 24.50 | 8.51 |
| — | +19.2% | +7.0% | -13.7% | -9.1% | -4.9% | -8.9% | -13.7% | -14.4% | -16.7% | +12.8% | +35.1% | +32.0% | |
| Current Ratio | 1.48 | 1.21 | 1.31 | 1.41 | 1.48 | 1.09 | 1.11 | 1.57 | 1.64 | 1.39 | 1.56 | 1.63 | 1.64 |
| — | +10.9% | +17.6% | -10.4% | -9.7% | -21.5% | -28.7% | -3.6% | -0.1% | +3.6% | +11.9% | +15.3% | -29.6% | |
| Quick Ratio | 0.88 | 0.41 | 0.56 | 0.73 | 0.88 | 0.34 | 0.54 | 0.90 | 1.09 | 0.54 | 0.89 | 1.03 | 1.13 |
| — | +17.9% | +4.3% | -18.6% | -18.8% | -35.7% | -39.5% | -11.9% | -3.5% | +14.4% | +42.4% | +36.4% | -36.7% | |
| Interest Coverage | 4.06 | 2.37 | 2.31 | 2.94 | 8.92 | 2.83 | 2.38 | 2.28 | 8.08 | 2.63 | 2.19 | 2.03 | 7.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonBath & Body Works, Inc.'s current P/E is 6.3x. The average P/E over the last 4 quarters is 15.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Bath & Body Works, Inc.'s current operating margin is 17.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Bath & Body Works, Inc.'s business trajectory between earnings reports.